MetaCap

Artivion (AORT) vs SpyGlass Pharma (SGP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SpyGlass Pharma is the larger company by market cap ($1.02 billion vs $886.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AORT-54.13%SGP+15.27%
+50%-4%-59%
Feb 6, 20261 yearNov 20, 2026
AORT-54.13%SGP+15.27%
+45%-7%-59%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AORT versus SGP key metrics
MetricAORTSGP
Share price$18.16$30.43
Market cap$886.02M$1.02B
1-day change-2.00%-1.14%
YTD return-60.18%—
1-year return-59.76%—
5-year return-0.82%—
Forward P/E34.92—
EPS (TTM)$-0.36$-2.70
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$441.33M—
Revenue growth (YoY)+13.59%—
Net income (latest FY)$9.77M$-39.87M
Gross margin64.40%—
Operating margin7.65%—
Net margin2.21%—
52-week high$48.25$39.92
52-week low$18.12$17.06
Distance from 52-week high-62.36%-23.77%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+111.84%+53.37%
Average volume671.97K114.63K
Shares outstanding48.79M33.46M
Employees1,80088
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Artivion

AORT stock →

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Health Care · Medical/Dental Instruments · 1,800 employees

About SpyGlass Pharma

SGP stock →

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.

Health Care · Medical/Dental Instruments · 88 employees

AORT vs SGP FAQ

Which is bigger, Artivion or SpyGlass Pharma?

SpyGlass Pharma (SGP) is larger, with a market capitalization of $1.02B compared with $886.02M for Artivion (AORT).

Are Artivion and SpyGlass Pharma in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons